You just read:

Debiopharm Progresses in Their Stand Against Drug-resistant N. Gonorrhoeae With Extended CARB-X Funding of Their Debio 1453 Antibiotic Program

News provided by

Debiopharm International SA

08 Nov, 2019, 08:00 GMT